⌘K

Home/Insiders/BELVIN MARCIA

BM

SEC Insider//CIK 0001970752

BELVIN MARCIA

CIK 00019707521 companySOUTH SAN FRANCISCO, CA

Transactions

11

Companies

1

Filings

5

CIK

0001970752

Recent Transactions

11 trades

Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20+11,250→ 179,829 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-08-20−11,250→ 0 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20$1.23/sh−4,181→ 175,648 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-03-19$2.09/sh−12,795→ 168,579 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-01-18+26,250→ 181,374 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-01-18+122,500→ 122,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-01-18+75,000→ 75,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-17+11,250→ 159,201 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-12-17−11,250→ 11,250 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-22$1.30/sh−4,119→ 147,951 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-20+11,250→ 152,070 total

Companies

1

CytomX Therapeutics, Inc.
SVP, Chief Scientific Officer
$CTMX

Recent Filings

5

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov